Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Acta Clin Belg ; 76(4): 280-288, 2021 Aug.
Article in English | MEDLINE | ID: mdl-32024450

ABSTRACT

Objective: To present an overview of almost two decades of multi-faceted campaigning by the Belgian Antibiotic Policy Coordination Committee (BAPCOC) and partners, and its impact on public and prescribers' awareness, outpatient antibiotic use, its cost and antimicrobial resistance in Belgium.Methods: Awareness of both public and prescribers was assessed through pre- and post-campaign interviews and surveys. Outpatient antibiotic use was evaluated using national reimbursement data expressed in number of defined daily doses and packages (a good proxy for treatments) per 1000 inhabitants per day (DID and PID, respectively) from July 1997 to June 2018. Its cost was studied using the same data expressed in number of euros per 1000 inhabitants per day. Antimicrobial resistance was evaluated between 1986 and 2017 using national data on the proportion of Streptococcus pneumoniae isolates not susceptible to penicillins, macrolides and tetracyclines.Results: Antibiotic awareness improved significantly, with general practitioners preferred by 87.5% of respondents as source of information. The Belgian outpatient antibiotic use has decreased by 12.8% in DID and by 42.8% in PID in the 2017-2018 winter compared to the winter before the start of its public awareness campaigns (1999-2000). This evolution coincided with decreasing costs for antibiotics and decreasing antimicrobial resistance. Despite multi-faceted campaigning, outpatient antibiotic use and use of broad-spectrum antibiotics, especially fluoroquinolones and amoxicillin with clavulanic acid, are still high in Belgium.Conclusion: Almost two decades of multi-faceted campaigning coincide with improvements in antibiotic awareness among the public and prescribers, outpatient antibiotic use and resistance. Nevertheless, additional efforts are needed to reach the targets set in BAPCOC's national action plan 2014-2019. Therefore, a new national action plan was developed for 2020-2024 using a One Health approach.


Subject(s)
Anti-Bacterial Agents , Fluoroquinolones , Anti-Bacterial Agents/therapeutic use , Belgium , Humans
2.
Transbound Emerg Dis ; 64(1): 130-136, 2017 Feb.
Article in English | MEDLINE | ID: mdl-25903854

ABSTRACT

An outbreak of intravascular catheter-related infections by extended-spectrum ß-lactamase (ESBL)-producing Escherichia coli in calves in an animal teaching hospital is reported. Pulsed-field gel electrophoresis was used for strain typing to determine the origin and dissemination of these strains. All 19 strains harboured the blaCTX-M-14, and six strains also overexpressed their chromosomal AmpC gene. Evidence on the introduction of the strain from a beef herd, experiencing neonatal diarrhoea and increased mortality, to the clinic through admission of diarrhoeic calves was provided. Strains isolated from phlebitis cases from other herds up to 5 months later showed a high similarity with the initial strain, suggesting that the strain had become nosocomial. The catheter infections with ESBL/AmpC-producing E. coli resulted in a prolonged hospitalization, increased anti-microbial use and mortality. This report points towards the potential dangers of the emergence of ESBL/AmpC-producing bacteria in susceptible food animals and warns farmers and veterinarians for the facility by which they are introduced into another environment.


Subject(s)
Bacterial Proteins/metabolism , Cattle Diseases/microbiology , Cross Infection/veterinary , Escherichia coli Infections/veterinary , Escherichia coli/physiology , beta-Lactamases/metabolism , Animals , Catheters/veterinary , Cattle , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field/veterinary , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Hospitals, Animal , Hospitals, Teaching
3.
Acta Clin Belg ; 70(3): 181-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25825036

ABSTRACT

BACKGROUND: Carbapenemase-producing Enterobacteriaceae (CPE) are emerging worldwide, representing a major threat for public health. Early CPE detection is crucial in order to prevent infections and the development of reservoirs/outbreaks in hospitals. In 2008, most of the CPE strains reported in Belgium were imported from patients repatriated from abroad. Actually, this is no longer the case. OBJECTIVES AND METHODS: A surveillance was set up in Belgian hospitals (2012) in order to explore the epidemiology and determinants of CPE, including the link with international travel/hospitalization. The present article describes travel-related CPE reported in Belgium. Different other potential sources for importation of CPE are discussed. RESULTS: Only 12% of all CPE cases reported in Belgium (2012-2013) were travel related (with/without hospitalization). This is undoubtedly an underestimation (missing travel data: 36%), considering the increasing tourism, the immigration from endemic countries, the growing number of foreign patients using scheduled medical care in Belgium, and the medical repatriations from foreign hospitals. The free movement of persons and services (European Union) contributes to an increase in foreign healthcare workers (HCW) in Belgian hospitals. Residents from nursing homes located at the country borders can be another potential source of dissemination of CPE between countries. Moreover, the high population density in Belgium can increase the risk for CPE-dissemination. Urban areas in Belgium may cumulate these potential risk factors for import/dissemination of CPE. CONCLUSIONS: Ideally, travel history data should be obtained from hospital hygiene teams, not from the microbiological laboratory. Patients who received medical care abroad (whatever the country) should be screened for CPE at admission.


Subject(s)
Bacterial Proteins/metabolism , Cross Infection , Enterobacteriaceae Infections , Enterobacteriaceae , Infection Control , Travel , beta-Lactamases/metabolism , Belgium/epidemiology , Cross Infection/diagnosis , Cross Infection/etiology , Cross Infection/prevention & control , Enterobacteriaceae/isolation & purification , Enterobacteriaceae/metabolism , Enterobacteriaceae Infections/diagnosis , Enterobacteriaceae Infections/etiology , Enterobacteriaceae Infections/prevention & control , Humans , Infection Control/organization & administration , Infection Control/statistics & numerical data , Microbial Sensitivity Tests , Needs Assessment , Risk Assessment
4.
J Hosp Infect ; 84(2): 120-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23639819

ABSTRACT

BACKGROUND AND AIM: To describe the methodology and output of the Belgian surveillance for infections acquired in intensive care units (ICUs) between 1997 and 2010. METHODS: Since 1997, ICUs in acute care hospitals in Belgium have been encouraged by federal law to participate in a national multi-centre prospective observational surveillance programme. A protocol and software tool for data collection was developed, and the case definitions and methodology follow those of the European Centre for Disease Prevention and Control. FINDINGS: For 2010, 18 hospitals provided data on 59 observation quarters, 6478 ICU patients and 52,593 ICU patient-days. The mean incidence rates of ICU-acquired pneumonia and intubation-associated pneumonia were 13 per 1000 patient-days and 12 per 1000 intubation-days, respectively. The mean incidence rates of ICU-acquired bloodstream infections, central vascular catheter (CVC)-associated bloodstream infections and CVC-associated primary bloodstream infections were 3.2 per 1000 patient-days, 2.6 per 1000 catheter-days and 2.3 per 1000 catheter-days, respectively. Between 1997 and 2010, stable trends in ICU-acquired pneumonia and bloodstream infections were observed, together with decreasing trends for intubation-associated pneumonia and CVC-associated bloodstream infections, and a stable trend for CVC-associated primary bloodstream infections. CONCLUSIONS: In Belgium, national surveillance of ICU-acquired infections allows acute care hospitals to track the incidence of infections at local level, enabling comparison with national and European reference data. Between 1997 and 2010, the incidence of ICU-acquired infections increased and the incidence of device-associated infections decreased.


Subject(s)
Cross Infection/epidemiology , Intensive Care Units , Belgium/epidemiology , Humans , Incidence , Prospective Studies
5.
Reprod Domest Anim ; 48(1): e1-6, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23317156

ABSTRACT

Hydrallantois in the mare is a very rare condition, and clinical reports help to gather information to elucidate its pathogenesis, treatment options and prognosis. Five different cases of hydrallantois in the mare are reported in this article, all with the involvement of placentitis. The five mares were presented because of acute distention of the abdomen, dyspnoea, stiff gait and a lack of appetite. After a gradual release of the excessive amount of allantoic fluid, an abortion was induced in all five mares. The foals were either born dead or euthanized. The mares recovered quickly. One mare conceived within the same season, one remained barren despite several cycles of natural breeding, and no data were available on the other three mares. In this series, the condition is reported for the first time in two Shetland ponies, both pregnant with foals sharing a close genetic background. In both cases, the condition led to hyperlipidemia. The condition as it occurs in nulliparous mares is also discussed. Finally, the possible involvement of placentitis in the pathogenesis is emphasized.


Subject(s)
Allantois/pathology , Horse Diseases/pathology , Placenta Diseases/veterinary , Abortion, Veterinary , Animals , Female , Horses , Placenta Diseases/pathology , Pregnancy , Stillbirth
6.
Epidemiol Infect ; 141(3): 490-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22677465

ABSTRACT

The Belgian data (2003-2010) for the European Antimicrobial Resistance Surveillance Network (EARS-Net) showed a significant decreasing trend in the proportion of penicillin non-susceptible Streptococcus pneumoniae (9·4% to <1%) from blood and CSF isolates. We found that 75% of this decrease was explained by a change in Clinical and Laboratory Standards Institute (CLSI) breakpoints as the trend disappeared if only the new breakpoints were applied. Applying only European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints also resulted in a relatively stable proportion of penicillin non-susceptibility (average 5%), but this proportion was 7-13 times higher than with the new CLSI breakpoints. When the new CLSI breakpoints alone are used, fewer than 1% of bacteraemia isolates were penicillin non-susceptible during the entire period, but the proportion of non-susceptible meningitis isolates rose from 6·3% in 2003 to 15·9% between 2003 and 2010. Changing breakpoints should lead to retrospective analysis of historical data to minimize wrongly interpreting resistance trends.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Penicillin G/pharmacology , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/drug effects , Bacteremia/microbiology , Belgium/epidemiology , Epidemiological Monitoring , Humans , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/standards , Pneumococcal Infections/epidemiology , Practice Guidelines as Topic , Streptococcus pneumoniae/isolation & purification
7.
Euro Surveill ; 17(46)2012 Nov 15.
Article in English | MEDLINE | ID: mdl-23171822

ABSTRACT

A standardised methodology for a combined point prevalence survey (PPS) on healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals developed by the European Centre for Disease Prevention and Control was piloted across Europe. Variables were collected at national, hospital and patient level in 66 hospitals from 23 countries. A patient-based and a unit-based protocol were available. Feasibility was assessed via national and hospital questionnaires. Of 19,888 surveyed patients, 7.1% had an HAI and 34.6% were receiving at least one antimicrobial agent. Prevalence results were highest in intensive care units, with 28.1% patients with HAI, and 61.4% patients with antimicrobial use. Pneumonia and other lower respiratory tract infections (2.0% of patients; 95% confidence interval (CI): 1.8­2.2%) represented the most common type (25.7%) of HAI. Surgical prophylaxis was the indication for 17.3% of used antimicrobials and exceeded one day in 60.7% of cases. Risk factors in the patient-based protocol were provided for 98% or more of the included patients and all were independently associated with both presence of HAI and receiving an antimicrobial agent. The patient-based protocol required more work than the unit-based protocol, but allowed collecting detailed data and analysis of risk factors for HAI and antimicrobial use.


Subject(s)
Anti-Infective Agents/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Drug Utilization Review/statistics & numerical data , Infection Control/statistics & numerical data , Population Surveillance/methods , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cross Infection/microbiology , Drug Utilization Review/methods , Europe/epidemiology , Feasibility Studies , Female , Government Agencies , Health Surveys , Hospitals/statistics & numerical data , Humans , Infant , Infant, Newborn , Infection Control/methods , Logistic Models , Male , Middle Aged , Prevalence , Risk Factors , Sex Distribution , Surveys and Questionnaires , Young Adult
8.
Euro Surveill ; 17(18)2012 May 03.
Article in English | MEDLINE | ID: mdl-22587957

ABSTRACT

Four consecutive one-month campaigns were organised to promote hand hygiene in Belgian hospitals between 2005 and 2011. The campaigns included a combination of reminders in wards, educational sessions for healthcare workers, promotion of alcohol-based hand rub use, increasing patient awareness, and audits with performance feedback. Prior and after each one month intervention period, the infection control teams measured hand hygiene compliance of healthcare workers by direct observation using a standardised observation roster. A total of 738,367 opportunities for hand hygiene were observed over the four campaigns. Compliance with hand hygiene significantly increased from 49.6% before to 68.6% after the intervention period for the first, from 53.2% to 69.5% for the second, from 58.0% to 69.1% for the third, and from 62.3% to 72.9% for the fourth campaign. The highest compliance rates were consistently observed in paediatric units. Compliance rates were always markedly lower among physicians than nurses. After patient contact and body fluid exposure risk, compliance rates were noticeably higher than before patient contact and performing aseptic procedures. We conclude that repeated countrywide campaigns to promote hand hygiene result in positive long-term outcomes. However, lower compliance rates among physicians compared with nurses, before patient contact, and before performing aseptic procedures remain challenges for future campaigns.


Subject(s)
Guideline Adherence/statistics & numerical data , Hand Disinfection/standards , Health Knowledge, Attitudes, Practice , Hospitals/standards , Hygiene/standards , Infection Control/methods , Belgium , Clinical Audit , Community Health Workers/organization & administration , Guideline Adherence/trends , Hospitals/statistics & numerical data , Humans , Hygiene/education , Medical Staff, Hospital/psychology , Medical Staff, Hospital/standards
9.
Eur J Clin Microbiol Infect Dis ; 31(9): 2283-92, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22382816

ABSTRACT

This study aimed to estimate the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carriage upon hospital admission and to study the molecular epidemiology of MRSA in order to assess the proportion of Panton-Valentine leukocidin (PVL)-positive community-associated (CA) and livestock-associated (LA) MRSA strains. Epidemiological data on MRSA carriage upon hospital admission (2006-2009) were collected in a compulsory, continuous, national MRSA surveillance in Belgian acute-care hospitals. Additionally, 328 MRSA strains in 2005 and 314 strains in 2008 were collected in a separate, multicenter microbiological survey. Spa-typing, SCCmec-typing and MLST were performed; toxin genes were detected by PCR. The overall prevalence of MRSA carriage upon hospital admission was 8.9 cases/1,000 admissions between 2006 and 2009. Of MRSA carriers, 37.5% had a known MRSA history, 39.4% had stayed in a care facility, 12.2% reported no contact with healthcare. Over 90% of MRSA belonged to five healthcare-associated clones. Of these, MRSA spa-CC038-ST45-IV was in decline, mainly in favor of spa-CC008-ST8-IV. MRSA spa-CC002-ST5-IV, spa-CC002-ST5-II and spa-CC032-ST22-IV remained relatively stable. The proportion of PVL-positive CA-MRSA and LA-MRSA ST398 was below 2% of all MRSA. The extra-hospital MRSA reservoir in Belgium mainly consists of persons with previous healthcare exposure. PVL-positive CA-MRSA and LA-MRSA strains remained infrequent among hospitalized patients.


Subject(s)
Carrier State/epidemiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacterial Toxins/genetics , Belgium/epidemiology , Carrier State/microbiology , Child , Child, Preschool , Cluster Analysis , Diagnostic Tests, Routine , Exotoxins/genetics , Female , Hospitals , Humans , Infant , Infant, Newborn , Leukocidins/genetics , Male , Middle Aged , Molecular Epidemiology , Molecular Typing , Prevalence , Risk Factors , Staphylococcal Infections/microbiology , Young Adult
10.
Epidemiol Infect ; 140(3): 383-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22082716

ABSTRACT

The prevalence and risk factors associated with livestock-associated MRSA (LA-MRSA) carriage was examined in Danish and Belgian veterinarians. The MRSA and LA-MRSA carriage rates were 9·5% (95% CI 5·3-15·6) and 7·5% (95% CI 3·8-13·1) for MRSA and LA-MRSA, respectively, in Belgium and 1·4% (95% CI: 0·17-5·05) in Denmark (all Danish MRSA isolates belonged to the LA-MRSA genotype). All LA-MRSA isolates were resistant to tetracycline and 53·4% (7/13) showed a multi-resistant phenotype. LA-MRSA was significantly associated with veterinarians in contact with livestock (P=0·046). In the multivariable analysis, working with small animals in a veterinary clinic seems to be negatively associated (OR 0·15, 95% CI 0-1·0, P=0·05) and a strong direct association was found for LA-MRSA acquisition and exposure to live pigs (OR 12·1, 95% CI 1·6-548·5, P=0·01). Since carriage of MRSA ST398 may increase the risk of complications during hospitalization, our results underline that preventive measures may need to be developed for veterinary professionals, particularly for livestock veterinarians.


Subject(s)
Carrier State/epidemiology , Carrier State/microbiology , Methicillin-Resistant Staphylococcus aureus/classification , Molecular Typing , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Veterinarians , Animals , Belgium , Denmark , Drug Resistance, Multiple, Bacterial , Genotype , Livestock , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Occupational Exposure , Prevalence , Risk Assessment , Swine
11.
Euro Surveill ; 16(43)2011 Oct 27.
Article in English | MEDLINE | ID: mdl-22085603

ABSTRACT

Surveillance of Clostridium difficile infection (CDI) is compulsory in Belgian hospitals. Our objectives were to compare incidence and case characteristics of nosocomial infections (Nc-CDI) with onset of diarrhoea more than two days after hospital admission, with non-nosocomial cases (Nnc-CDI). The database included inpatients from 2008 to 2010. Of 8,351 cases reported by 150 hospitals, 3,102 (37%) were classified as Nnc-CDI and 5,249 (63%) as Nc-CDI. In 2010, the mean incidence per 1,000 admissions was 0.95 for Nc-CDI and 0.56 for Nnc-CDI. Both incidences were relatively stable over the three years, with a slight decrease in 2010 (p<0.01). Onset of symptoms in Nnc- CDI cases took place in the community (57.1%), nursing homes (14.2%) or hospitals (17.5%); data for 11.2%were missing. Nnc-CDI cases were younger than Nc-CDI (median age 75 vs. 79 years, p<0.001), and more likely to be women (62% vs. 57%, p<0.001) and to have pseudomembranous colitis (5.3% vs. 1.6%, p<0.001). In 2009, C. difficile ribotype 027 was found in 32 of 70 reporting hospitals compared with 19 of 69 in 2010 (p<0.03). Although our study population only included hospitalised patients, the results do not support the hypothesis of an increase in the incidence of severe community-associated CDI.


Subject(s)
Clostridioides difficile , Clostridium Infections/epidemiology , Cross Infection/epidemiology , Age Distribution , Aged , Aged, 80 and over , Belgium/epidemiology , Clostridioides difficile/classification , Clostridioides difficile/isolation & purification , Female , Hospitalization , Hospitals/statistics & numerical data , Humans , Incidence , Male , Middle Aged , Population Surveillance , Ribotyping
12.
Vet Rec ; 169(11): 278, 2011 Sep 10.
Article in English | MEDLINE | ID: mdl-21831999

ABSTRACT

The prevalence of respiratory pathogens in diseased veal calves was determined in 24 respiratory disease outbreaks in 15 herds in Belgium. Bacteria were cultured from nasopharyngeal swabs and seroconversion against viruses and Mycoplasma bovis was determined on paired sera. At the individual calf level, Mycoplasma species, Mannheimia haemolytica and Pasteurella multocida, were isolated from 70.5 per cent, 21.5 per cent and 26.0 per cent of swabs, respectively. At the herd level, the presence of M bovis could be confirmed in 84.6 per cent of the herds examined. Seroconversion against bovine viral diarrhoea virus (BVDV) was present in 71.4 per cent of herds, parainfluenzavirus type 3 in 53.3 per cent, bovine respiratory syncytial virus in 40.0 per cent, bovine adenovirus type 3 in 46.7 per cent, bovine coronavirus in 30.0 per cent, and bovine herpesvirus type 1 in 26.7 per cent. At postmortem examination, Mycoplasma species could be cultured from 61.9 per cent of pneumonic lungs (n=21). Sixty per cent of calves tested were positive for BVDV (n=20), and 20.0 per cent were positive for bovine respiratory syncytial virus (n=16).


Subject(s)
Cattle Diseases/microbiology , Disease Outbreaks/veterinary , Lung/microbiology , Respiratory Tract Infections/veterinary , Animals , Antibodies, Bacterial/blood , Antibodies, Viral/blood , Belgium/epidemiology , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/etiology , Cattle Diseases/virology , Lung/virology , Mycoplasma/immunology , Mycoplasma/isolation & purification , Respiratory Syncytial Virus, Bovine/immunology , Respiratory Syncytial Virus, Bovine/isolation & purification , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/microbiology , Respiratory Tract Infections/virology , Species Specificity
13.
Epidemiol Infect ; 139(5): 765-71, 2011 May.
Article in English | MEDLINE | ID: mdl-20587122

ABSTRACT

A cross-sectional study on 32 different Belgian broiler farms was performed in 2007 and 2008 to identify risk factors for ceftiofur resistance in Escherichia coli. On each farm, one E. coli colony was isolated from 30 random birds. Following susceptibility testing of 14 antimicrobials, an on-farm questionnaire was used to obtain information on risk factors. Using a multilevel logistic regression model two factors were identified at the animal level: resistance to amoxicillin and to trimethoprim-sulfonamide. On the farm level, besides antimicrobial use, seven management factors were found to be associated with the occurrence of ceftiofur resistance in E. coli from broilers: poor hygienic condition of the medicinal treatment reservoir, no acidification of drinking water, more than three feed changes during the production cycle, hatchery of origin, breed, litter material used, and treatment with amoxicillin. This study confirms that not only on-farm antimicrobial therapy, but also management- and hatchery-related factors influence the occurrence of antimicrobial resistance.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Drug Resistance, Bacterial , Escherichia coli Infections/veterinary , Escherichia coli/drug effects , Escherichia coli/isolation & purification , Animals , Belgium , Chickens , Cross-Sectional Studies , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Microbial Sensitivity Tests , Risk Factors , Surveys and Questionnaires
14.
J Appl Microbiol ; 110(2): 541-9, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21143712

ABSTRACT

AIMS: The behaviour of an Escherichia coli isolate of broiler origin harbouring a bla(TEM-52) -carrying plasmid (lactose-negative mutant of B1-54, IncII group) was studied in an in situ continuous flow culture system, simulating the human caecum and the ascending colon during cefotaxime administration. METHODS AND RESULTS: Fresh faeces from a healthy volunteer, negative for cephalosporin-resistant E. coli, were selected to prepare inocula. The microbiota was monitored by plating on diverse selective media, and a shift in the populations of bacteria was examined by 16S rDNA PCR denaturing gradient gel electrophoresis. Escherichia coli transconjugants were verified by plasmid and pulsed-field gel electrophoresis profiles (PFGE). The avian extended-spectrum ß-lactamase-positive E. coli was able to proliferate without selective pressure of cefotaxime, and E. coli transconjugants of human origin were detected 24 h after inoculation of the donor strain. Upon administration of cefotaxime to the fresh medium, an increase in the population size of E. coli B1-54 and the transconjugants was observed. PFGE and plasmid analysis revealed a limited number of human E. coli clones receptive for the bla(TEM-52) -carrying plasmid. CONCLUSIONS: These observations provide evidence of the maintenance of an E. coli strain of poultry origin and the horizontal gene transfer in the human commensal bowel microbiota even without antimicrobial treatment. SIGNIFICANCE AND IMPACT OF THE STUDY: The fact that an E. coli strain of poultry origin might establish itself and transfer its bla gene to commensal human E. coli raises public health concerns.


Subject(s)
Conjugation, Genetic , Escherichia coli/genetics , Gene Transfer, Horizontal , Poultry/microbiology , beta-Lactamases/genetics , Animals , Anti-Bacterial Agents/pharmacology , Cecum/microbiology , Cefotaxime/pharmacology , Colon/microbiology , Denaturing Gradient Gel Electrophoresis , Electrophoresis, Gel, Pulsed-Field , Escherichia coli/growth & development , Escherichia coli/isolation & purification , Humans , Plasmids/genetics , Polymerase Chain Reaction
15.
Epidemiol Infect ; 138(5): 626-44, 2010 May.
Article in English | MEDLINE | ID: mdl-20141646

ABSTRACT

The scope of this reflection paper was to review the latest research on the risk of MRSA infection and colonization in animals. Attention focused on occurrence, risk factors for colonization and infection, and human contact hazard for livestock, horses, and companion animals. Whereas the clonal relationship between MRSA strains of CC398 is straightforward in livestock this is less obvious in horses. Small companion animals typically share MRSA strains that seem to exchange with a human reservoir. Management and therapeutic options have been suggested for livestock, horses, companion animals, as well as instructions on safety measures for persons in contact with animals. Conclusions were drawn with emphasis on future research activities, especially to confirm the apparent evolution of the organism and to demonstrate efficiency of control strategies.


Subject(s)
Animals, Domestic/microbiology , Carrier State/veterinary , Infection Control/methods , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/veterinary , Zoonoses/epidemiology , Animals , Carrier State/epidemiology , Carrier State/microbiology , Carrier State/transmission , Food Microbiology , Humans , Staphylococcal Infections/epidemiology , Staphylococcal Infections/microbiology , Staphylococcal Infections/transmission , Zoonoses/microbiology , Zoonoses/transmission
16.
J Vet Pharmacol Ther ; 31(5): 479-87, 2008 Oct.
Article in English | MEDLINE | ID: mdl-19000268

ABSTRACT

The efficacy of an injectable formulation of florfenicol (300 mg/mL) as metaphylactic control of naturally occurring bovine respiratory disease (BRD) was evaluated in two double-blind randomly controlled field studies on two Dutch veal calf herds (A and B). Cattle aged not older than 3 months and in the direct presence of calves with clinical respiratory disease were randomly allocated to treatment with 40 mg/kg florfenicol subcutaneously (s.c.) a positive control treatment (12.5 mg/kg tilmicosin p.o. twice daily for five consecutive days in herd A, and 12.5 mg/kg doxycycline p.o. twice daily for five consecutive days in herd B), or a negative control (one placebo saline s.c. administration on D0). The predominant respiratory pathogens present in pretreatment respiratory samples from affected animals were Mycoplasma bovis and Pasteurella multocida in outbreaks A and B, respectively. Metaphylactic administration of florfenicol resulted in a statistically significant weight gain, decreased rectal temperature for five consecutive days after treatment and decreased metaphylactic failure percentages compared with both positive and negative control groups. In summary, these studies demonstrated that a single s.c. injection of florfenicol is effective and practical for control of the bacterial component of BRD in veal calves.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cattle Diseases/drug therapy , Disease Outbreaks/veterinary , Mycoplasma Infections/veterinary , Mycoplasma bovis/isolation & purification , Pasteurella Infections/veterinary , Pasteurella multocida/isolation & purification , Respiratory Tract Infections/veterinary , Thiamphenicol/analogs & derivatives , Tylosin/analogs & derivatives , Animals , Body Temperature , Body Weight , Cattle , Cattle Diseases/epidemiology , Disease Outbreaks/prevention & control , Male , Mycoplasma Infections/drug therapy , Mycoplasma bovis/pathogenicity , Netherlands , Pasteurella Infections/drug therapy , Pasteurella multocida/pathogenicity , Respiratory Tract Infections/drug therapy , Respiratory Tract Infections/microbiology , Thiamphenicol/therapeutic use , Tylosin/therapeutic use
17.
Prev Vet Med ; 78(3-4): 339-51, 2007 Mar 17.
Article in English | MEDLINE | ID: mdl-17156871

ABSTRACT

Between March and October 2003 a field study was conducted in 50 randomly selected pig herds to assess the degree of tetracycline-resistance in lactose-positive enteric coliforms (LPEC) originating from fattening pigs and to evaluate the combined effects of various husbandry conditions on the development and persistence of antimicrobial-resistant bacteria. Data on housing, management and antimicrobial-drug consumption were collected, as well as faecal samples at three production stages: end of the nursery period (mean age: 72 days), end of the grower period (mean age: 125 days) and end of the finisher period (mean age: 186 days). The degree of tetracycline-resistant LPEC was determined by means of an agar dilution method. Tetracycline-resistant LPEC were found in every herd. The overall degree of tetracycline-resistance in LPEC was 56.8% (S.D. 22.4%). Only a very weak relation was found between the degrees of TETR in the different production stages within the same herd, indicating that the degree of TETR is mainly associated with the production stage rather than with the farm as a whole. The risk factor analysis showed that besides the antimicrobial-drug use, other factors like inside pen hygiene can influence the development and maintenance of antimicrobial-resistant bacteria in the gastrointestinal tracts of pigs. It was also observed that tetracycline-resistance in commensal Escherichia coli is often linked with resistance to other antimicrobial drugs like ampicillin and trimethoprim-sulphonamides. These results illustrate that the epidemiology of antimicrobial resistance is influenced by antimicrobial-drug use, cross-resistance development and non-antimicrobial risk factors.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Enterobacteriaceae Infections/veterinary , Enterobacteriaceae/drug effects , Swine Diseases/drug therapy , Swine Diseases/microbiology , Tetracycline Resistance , Tetracycline/therapeutic use , Animal Husbandry/methods , Animals , Belgium , Colony Count, Microbial/veterinary , Drug Resistance, Multiple, Bacterial , Enterobacteriaceae/growth & development , Enterobacteriaceae Infections/drug therapy , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/prevention & control , Feces/microbiology , Lactose/metabolism , Microbial Sensitivity Tests/veterinary , Risk Factors , Surveys and Questionnaires , Swine , Swine Diseases/prevention & control
18.
Vet Res Commun ; 30(7): 707-15, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17004035

ABSTRACT

The aim of the present study was to determine which Pasteurella and Mannheimia species are present in the upper respiratory tract of healthy calves with no history of antimicrobial treatment prior to sampling. The presence of subpopulations of tetracycline-resistant Pasteurellaceae was also investigated. Nasal swabs from 61 loose group-housed, clinically healthy calves, 1 to 4 months old, from 16 dairy herds were inoculated aerobically on a selective medium (Columbia agar with 5% ovine blood and 16 mg/L bacitracin) with or without 4 mg/L oxytetracycline (OTC). A total of 43 strains belonging to the family Pasteurellaceae were isolated from 38 calves (62.3%) out of 13 herds (81.3%). The predominant organisms were Pasteurella multocida subsp. multocida (57.4%), Mannheimia varigena (4.9%) and M. haemolytica (3.2%). Growth of Pasteurellaceae on the OTC-containing medium was seen only with samples from two herds (6 animals; 9.8%), and on only one farm this proved to be an OTC-resistant subpopulation. Minimum inhibitory concentration (MIC) determinations by means of agar dilution confirmed a low prevalence of OTC-resistant Pasteurellaceae, with overall MIC(50) and MIC(90) values of 0.25 and 32 mg/L, respectively. These data do not support the hypothesis that the relative high frequency of tetracycline-resistant P. multocida isolates from fatal cases of bovine respiratory disease is related to the presence of minor tetracycline-resistance subpopulations within this species.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cattle Diseases/drug therapy , Nasopharynx/microbiology , Pasteurellaceae Infections/veterinary , Pasteurellaceae/drug effects , Tetracycline Resistance , Animals , Cattle , Cattle Diseases/microbiology , Colony Count, Microbial/veterinary , Dose-Response Relationship, Drug , Mannheimia/drug effects , Microbial Sensitivity Tests/veterinary , Pasteurella/drug effects , Pasteurellaceae Infections/drug therapy , Pasteurellaceae Infections/microbiology , Prevalence
19.
Microb Drug Resist ; 12(1): 74-81, 2006.
Article in English | MEDLINE | ID: mdl-16584313

ABSTRACT

The aim of this study was to determine the prevalence of antibiotic resistance and different resistance patterns for Salmonella isolates collected from Belgian sows and fattening pigs at different ages and at slaughter. The most frequently isolated serotypes were S. Typhimurium (42.3%), S. Derby (25.1%), S. Goldcoast (7.3%), and S. Infantis (4.8%). All 901 isolates were submitted to antimicrobial susceptibility testing for 14 compounds using the disc agar diffusion test. The highest percentage of resistance was found to oxytetracycline (34.2%), streptomycin (32.5%), sulfamethizole (27.6%), and ampicillin (24.9%). Three of the isolates showed resistance to cephalosporins and none to second-generation fluoroquinolones. Multiresistance (resistance to > or =2 antimicrobials) was observed in 33.2% of the strains. Differences in resistance patterns were observed between and within serotypes as well as genotypes. A significant lower proportion (p < 0.01) of resistant strains was recovered in fecal samples from sows (23/56) than from fattening pigs during the weaning (30/30), growing (79/85), and finishing periods (45/52). The proportion of resistant strains recovered from fecal samples taken at the herd (154/167) was higher than in the samples collected at the slaughterhouse (75/140). When designing antimicrobial resistance surveillance programs for Salmonella in pigs, it is important to take multiple samples within each herd from both sows and fattening pigs at different time points.


Subject(s)
Salmonella enterica/classification , Swine/microbiology , Animals , Drug Resistance, Bacterial , Female , Microbial Sensitivity Tests , Salmonella enterica/drug effects , Serotyping
20.
Res Vet Sci ; 77(3): 187-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15276768

ABSTRACT

Mannheimia varigena was identified as the etiologic agent of meningitis in a young Belgian White Blue heifer calf. Species identification of the bacterium was done by phenotyping and molecularly confirmed by tDNA-PCR. Standard bacteriological examination might fail to differentiate species belonging to the genus Mannheimia.


Subject(s)
Cattle Diseases/microbiology , Mannheimia/isolation & purification , Meningitis, Bacterial/veterinary , Pasteurellaceae Infections/veterinary , Animals , Bacterial Typing Techniques/veterinary , Cattle , DNA, Bacterial/analysis , Drug Resistance, Microbial/physiology , Fatal Outcome , Female , Mannheimia/classification , Mannheimia/genetics , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/microbiology , Pasteurellaceae Infections/diagnosis , Pasteurellaceae Infections/microbiology , Polymerase Chain Reaction/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...